Understanding Your Cholesterol Report

Apolipoprotein B (ApoB): Counting the Particles

Here is a concept that changes how you think about cholesterol. LDL-C tells you how much cholesterol is being carried, but it does not tell you how many particles are carrying it. Every atherogenic (plaque-forming) particle — LDL, VLDL, and remnants — carries exactly one molecule of apolipoprotein B on its surface. So measuring ApoB effectively counts the total number of harmful particles in your blood.

Why does this matter?

Because it is the number of particles battering your artery walls that drives plaque formation, not just the cholesterol they contain. Some people — especially those with diabetes, insulin resistance, high triglycerides, or the "cholesteroldepleted" small dense LDL pattern common in South Asians — carry a large number of small particles. Their LDL-C can look reassuringly normal while their ApoB, and therefore their real risk, is high. This mismatch, called discordance, hides risk that a standard report would miss entirely. The LAI treats LDL-C as the primary treatment target, non-HDL cholesterol as the co-primary target, and ApoB as a secondary target. ApoB is considered particularly valuable in people with diabetes, high triglycerides, obesity, or very low LDL who have already hit their LDL goal but may still carry residual risk. General ApoB goals used in aggressive lipid management are broadly:

• Below 65 mg/dL for very-high and extreme-risk individuals

• Below 80 mg/dL for high-risk individuals

• Below 90 mg/dL for those at lower risk

If your LDL looks fine but your ApoB is elevated, that is a signal your doctor may want to intensify treatment.

Lipoprotein(a), or Lp(a): The Risk You Inherit

Lp(a) is one of the most underappreciated cardiovascular risk factors, and it behaves differently from everything else on your report. It is an LDL-like particle with an extra protein attached, and its level is almost entirely determined by your genes. Diet, exercise, and most standard cholesterol medications have little effect on it. You are essentially born with your Lp(a) level, and it stays fairly stable for life. High Lp(a) independently raises the risk of heart attack, stroke, and narrowing of the aortic heart valve — even in people whose LDL and everything else looks perfect. It is thought to be both pro-atherogenic (plaque-forming) and pro-thrombotic (clotpromoting). Because it is inherited, a high result also carries implications for your close family members, who may want to be tested

Two practical points follow from its genetic nature:

1. You usually only need to test it once in your lifetime. Since the level doesn't change much, the LAI notes that a one-time measurement is sufficient to assess this risk. There is currently no widely available drug specifically approved to lower Lp(a), though several are in clinical trials.

2. An elevated level means you should be more aggressive about everything else you can control — LDL, blood pressure, blood sugar, smoking, and weight. A commonly used threshold for concern is Lp(a) of 50 mg/dL (roughly 125 nmol/L) or higher, which is associated with a meaningfully increased risk of cardiovascular disease. Given how common elevated Lp(a) is in South Asians, testing it at least once is a sensible idea, particularly if heart disease runs in your family.

Apolipoprotein A1 and the ApoB/ApoA1 Ratio: The Balance That Predicts Risk

If ApoB counts the harmful particles, apolipoprotein A1 (ApoA1) counts the protective ones. ApoA1 is the main structural protein of HDL, the "good" cholesterol, and it does the useful work — pulling excess cholesterol out of artery walls and carrying it back to the liver, and helping keep the artery lining healthy. A higher ApoA1 generally reflects more functional protection, while a low ApoA1 signals that your defence system is weak. The real power comes from putting the two together. The ApoB/ApoA1 ratio captures, in a single number, the tug-of-war between the particles driving plaque into your arteries (ApoB) and the particles clearing it out (ApoA1). A high ratio means the harmful side is winning; a low ratio means your protection has the upper hand. Because it directly compares atherogenic and protective particles, this ratio often reflects true cardiovascular risk better than any single cholesterol value. Why this ratio deserves special attention:

• It was the single strongest predictor in the INTERHEART study — a landmark investigation of heart attacks across 52 countries, including India and other South Asian populations. Of nine major risk factors examined, the ApoB/ApoA1 ratio carried the greatest predictive power for heart attack, outperforming every conventional cholesterol measure and every other lipid ratio such as LDL-C/HDL-C or total-cholesterol/HDL-C.

• It works even when LDL looks normal. The ratio predicts the thickening of artery walls and the presence of vulnerable, rupture-prone plaque across all levels of LDL cholesterol, which is exactly why it catches hidden risk.

• It is independent of age, sex, and ethnicity, and can be measured on a simple non-fasting blood sample.

• It is directly relevant to us, since the INTERHEART data included South Asians, among whom this ratio is a robust marker of the premature heart disease we are prone to. Commonly used reference bands for the ApoB/ApoA1 ratio (laboratories may vary slightly) are roughly:

In short, a low ApoB paired with a high ApoA1 — a low ratio — is the profile you want. If your ratio is high, it is a strong signal to act on your modifiable risk factors and discuss treatment with your doctor, even if individual numbers on the basic panel look acceptable.